All posts tagged lung cancer

  • Camidge.Slider.940x530

    University of Colorado’s Online Screening for Rare Lung Cancer Subtypes Opens Door to New Kind of Clinical Trial

    CU Cancer Center clinical trial tests the drug ponatinib against lung cancer with mutation in the gene FGFR1. Online questionnaire and free lung cancer tissue testing at CU determines eligibility.

Tabitha Sophia
Executive headshots
Ross Camidge, MD, PhD
CU Cancer Center Director, Dan Theodorescu, MD, PhD, shows a specific microRNA that may be necessary for bladder cancer metastasis.